Surgery Partners (SGRY) Cash from Financing Activities (2014 - 2026)

Surgery Partners has disclosed Cash from Financing Activities across 13 years of filings, most recently posting -$5.1 million for Q2 2026.

• In Q2 2026, Cash from Financing Activities rose 91.85% year-over-year to -$5.1 million; the TTM figure through Jun 2026 stood at -$85.9 million (down 1134.94% YoY), while the FY2025 annual figure was -$57.3 million, down 121.87% from the prior year.
• Cash from Financing Activities came in at -$5.1 million for Q2 2026 at Surgery Partners, up from -$55.9 million in the prior quarter.
• In the past five years, Cash from Financing Activities ranged from a high of $193.1 million in Q4 2022 to a low of -$84.1 million in Q3 2025.
• Average Cash from Financing Activities over 5 years is $1.7 million, with a median of -$30.8 million recorded in 2023.
• Year-over-year, Cash from Financing Activities soared 486.94% in 2024 and slumped 1052.05% in 2025.
• Over 5 years, Cash from Financing Activities stood at $193.1 million in 2022, then plunged by 123.1% to -$44.6 million in 2023, then jumped by 207.62% to $48.0 million in 2024, then climbed by 23.33% to $59.2 million in 2025, then sank by 108.61% to -$5.1 million in 2026.
• Per Business Quant data, the three most recent Cash from Financing Activities figures were -$5.1 million in Q2 2026, -$55.9 million in Q1 2026, and $59.2 million in Q4 2025.